Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.145 AUD Market Closed
Market Cap: 42.4m AUD

Relative Value

The Relative Value of one NXS stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.145 AUD, Next Science Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NXS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

NXS Competitors Multiples
Next Science Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Next Science Ltd
ASX:NXS
42.4m AUD 1.3 -3 -2.5 -2.5
JP
Hoya Corp
TSE:7741
8.5T JPY 9.5 40.5 25.1 30
CH
Alcon AG
SIX:ALC
31.7B CHF 4 38.5 20.4 39.6
US
Medline Inc
NASDAQ:MDLN
35B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
123.7B DKK 4.4 34 15.7 18.6
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD 3.1 32.3 14.7 18.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.6B CNY 9.8 27.1 24.5 24.5
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 0 0.3 0 0
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD 1.2 -20.1 19.8 93.5
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF 5.7 22.9 14.9 20.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD 3.3 40.9 18.6 31
P/E Multiple
Earnings Growth PEG
AU
Next Science Ltd
ASX:NXS
Average P/E: 29.6
Negative Multiple: -3
N/A N/A
JP
Hoya Corp
TSE:7741
40.5
13%
3.1
CH
Alcon AG
SIX:ALC
38.5
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
34
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
32.3
27%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.1
10%
2.7
UK
ConvaTec Group PLC
LSE:CTEC
0.3
33%
0
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -20.1 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
22.9
34%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
40.9
30%
1.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Next Science Ltd
ASX:NXS
Average EV/EBITDA: 17.1
Negative Multiple: -2.5
N/A N/A
JP
Hoya Corp
TSE:7741
25.1
11%
2.3
CH
Alcon AG
SIX:ALC
20.4
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.7
8%
2
US
Align Technology Inc
NASDAQ:ALGN
14.7
13%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.5
15%
1.6
UK
ConvaTec Group PLC
LSE:CTEC
0
10%
0
CA
Bausch + Lomb Corp
NYSE:BLCO
19.8
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14.9
21%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
18.6
16%
1.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Next Science Ltd
ASX:NXS
Average EV/EBIT: 30.7
Negative Multiple: -2.5
N/A N/A
JP
Hoya Corp
TSE:7741
30
N/A N/A
CH
Alcon AG
SIX:ALC
39.6
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.6
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.6
15%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.5
11%
2.2
UK
ConvaTec Group PLC
LSE:CTEC
0
22%
0
CA
Bausch + Lomb Corp
NYSE:BLCO
93.5
60%
1.6
CH
Ypsomed Holding AG
SIX:YPSN
20.2
29%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
31
30%
1